I am great full that someone else saw what I saw. And the abrupt change back to its previous image tells me that someone assumed the blurred image was not discernible.

So we will have to wait until they announce it more specifically. Nevertheless, it is great news for our future growth.

Many investors here may not realize that gaining only 5% of the test strip market for JNJ and eventually Abbot, is huge for Decision Diagnostics. And my bet is that it will be a much higher percentage . And, due to the improved design over the original JNJ strips, it will be well received.

But the Freestyle version will not be ready for USA sales for a while. FDA approval takes time. I think we will see a FDA approved test strip reader for GenUltimate sooner.